English | Español
Gene Johnson | Mar 9, 2017

Sigma-Tau Pharmaceuticals changes name to Leadiant Biosciences
Gene Johnson | Mar 9, 2017

Ferring, Foresee Pharmaceuticals enter exclusive development deal
Robert Lawson | Mar 9, 2017

AMA writes amicus brief to support proper medical testimony
Gene Johnson | Mar 9, 2017

FDA approves Qtern for treatment of Type 2 diabetes
Gene Johnson | Mar 9, 2017

Aurinia Pharmaceuticals CEO speaks at health care conference
Gene Johnson | Mar 9, 2017

Registration open for National Psoriasis Foundation's biennial conference

Gene Johnson | Mar 9, 2017

Survey shows diabetics unaware of increased risk for serious illnesses
Erianne Leatherman | Mar 8, 2017

Study reveals adolescents with Type 2 diabetes more susceptible to complications

Trending
Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
+ Pharmaceuticals
Patient Daily | Aug 23, 2025

Cleaner manufacturing could prevent thousands of deaths in New England